Skip to main content
. 2024 Mar 20;159(6):606–614. doi: 10.1001/jamasurg.2024.0184

Table 3. Operative Details of Patients in the MOABP and MBP Plus Placebo Groups.

Characteristic No. (%)
MBP plus placebo (n = 288) MOABP (n = 277)
Anterior resection and anastomosis type
Colorectal anastomosis
Partial TME 99 (34.4) 97 (35.0)
Total TME 165 (57.3) 160 (57.8)
Coloanal anastomosis 24 (8.3) 20 (7.2)
Surgical approach
Open 217 (75.3) 210 (75.8)
Laparoscopic 28 (9.7) 26 (9.4)
Robotic 34 (11.8) 37 (13.4)
Laparoscopic or robotic converted to open 9 (2.8) 4 (1.5)
Perioperative details
Timing of preoperative IV antibiotic administration before incision, median (IQR), min 26.0 (17.0-35.0) 27.0 (18.0-36.0)
Duration of operation, median (IQR), min 142.5 (119.0-186.0) 143.0 (119.0-180.0)
Estimated intraoperative blood loss, median (IQR), mL 150.0 (50.0-250.0)a 150.0 (50.0-200.0)
Anastomotic height from anal verge, median (IQR), cm 5.00 (4.0-7.0) 5.0 (4.0-7.0)
Protective loop ostomy
Transversostomy 193 (67.0) 173 (62.5)
Ileostomy 29 (10.1) 23 (8.3)
No stoma 66 (22.9) 81 (29.2)

Abbreviations: IV, intravenous; MBP, mechanical bowel preparation; MOABP, mechanical and oral antibiotics bowel preparation; TME, total mesorectal excision.

a

Data missing for 2 patients; patients with missing data were not included in calculations.